Innoviva, Inc. (INVA)
22.03
-0.15
(-0.68%)
USD |
NASDAQ |
Mar 06, 16:00
22.04
+0.01
(+0.05%)
After-Hours: 20:00
Innoviva Free Cash Flow : 195.80M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Nektar Therapeutics | -190.35M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Oramed Pharmaceuticals, Inc. | -11.03M |
| Theravance Biopharma, Inc. | 243.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 54.51M |
| Cash from Investing (Quarterly) | 23.64M |
| Cash from Financing (Quarterly) | -3.721M |
| Free Cash Flow Per Share (Quarterly) | 0.6392 |
| Free Cash Flow to Equity (Quarterly) | 44.45M |
| Free Cash Flow to Firm (Quarterly) | 57.29M |
| Free Cash Flow Yield | 11.20% |